Sign In
Buy NVAX
$7.89
-0.0600 (-0.755%)
At Close: Aug 10, 2026
Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript
02:33pm, Wednesday, 19'th Nov 2025
Novavax, Inc. ( NVAX ) Jefferies London Healthcare Conference 2025 November 19, 2025 11:30 AM EST Company Participants Ruxandra Draghia-Akli - Executive VP and Head of Research & Development James Kel
Shah Capital pushes for Novavax sale, warns of proxy fight
04:41pm, Wednesday, 12'th Nov 2025
Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a potential sale, and warned it could launch a proxy fight if no progress is
Novavax to Participate in Jefferies London Healthcare Conference
08:00am, Wednesday, 12'th Nov 2025
GAITHERSBURG, Md. , Nov. 12, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference: Jefferies London Healthcare Conf
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 11'th Nov 2025
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax Q3 Earnings & Revenues Beat Estimates, '25 Sales View Raised
12:31pm, Friday, 07'th Nov 2025
NVAX exceeds third-quarter expectations, boosted by a Sanofi milestone payment. It lifts its 2025 sales outlook.
Novavax, Inc. (NVAX) Q3 2025 Earnings Call Transcript
03:26pm, Thursday, 06'th Nov 2025
Novavax, Inc. ( NVAX ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants John Jacobs - President, CEO & Director Ruxandra Draghia-Akli - Executive VP and Head of Research & Devel
Novavax (NVAX) Reports Q3 Loss, Beats Revenue Estimates
10:16am, Thursday, 06'th Nov 2025
Novavax (NVAX) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $1.08. This compares to a loss of $0.76 per share a year ago.
Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights
08:00am, Thursday, 06'th Nov 2025
Total revenue of $70 million in the third quarter of 2025 Continued successful execution of Sanofi partnership with $225 million in milestones achieved year-to-date including $50 million earned on mar
Novavax raises annual revenue forecast on strength of vaccine deals
07:58am, Thursday, 06'th Nov 2025
Novavax raised its annual revenue forecast for the third time this year on Thursday, banking on milestone payments from vaccine supply and licensing deals such as with Japan's Takeda Pharmaceuticals.
Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment
07:00am, Tuesday, 04'th Nov 2025
Novavax has successfully achieved U.S. BLA approval and completed both EU and U.S. marketing authorization transfers for Nuvaxovid™ to Sanofi in line with its CLA and its corporate strategy, securin
Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025
08:00am, Thursday, 30'th Oct 2025
GAITHERSBURG, Md. , Oct. 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its third quarter 2025 financial results and operational highlights at 8:30 a.m.
Novavax (NVAX) Stock Sinks As Market Gains: Here's Why
06:46pm, Tuesday, 28'th Oct 2025
In the latest trading session, Novavax (NVAX) closed at $8.52, marking a -2.07% move from the previous day.
Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to Note
06:45pm, Wednesday, 22'nd Oct 2025
Novavax (NVAX) closed the most recent trading day at $8.46, moving 1.51% from the previous trading session.
Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy
07:00am, Wednesday, 22'nd Oct 2025
Agreements signed to transfer one U.S.-based facility and sell certain equipment netting $60 million in cash and resulting in future cash savings of $230 million Novavax headquarters to remain in Gait
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Tuesday, 21'st Oct 2025
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
